SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Motilal Oswal Recommends Buying Symbiotec Pharmalab, Sets Rs 1,430 Target

Motilal Oswal’s research report recommends buying Symbiotec Pharmalab and sets a target of Rs 1,430.

Related stories